PHK
AVEO

Point72 Hong Kong’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Point72 Hong Kong’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-467
Closed -$4K – 1884
2022
Q3 		$4K Buy
+467
New +$3.59K ﹤0.01% 1821
2019
Q2 		– Sell
-1,570
Closed -$13K – 1541
2019
Q1 		$13K Buy
+1,570
New +$16.2K 0.01% 735

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Point72 Hong Kong's AVEO Position: Q4 2022 in Review

Point72 Hong Kong sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 467 shares — an estimated $4K sold.

Point72 Hong Kong first reported a position in AVEO in Q1 2019 and held it in 2 quarters. The position peaked at $13K in Q1 2019. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • Point72 Hong Kong reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 467 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $4K.
  • Point72 Hong Kong first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2019 and held it in 2 quarters.
  • Point72 Hong Kong's AVEO Pharmaceuticals, Inc. position peaked at $13K in Q1 2019.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.